Trial Information

Summary: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.

This clinical study (The Parkinson’s Disease Study) is examining an investigational medication for safety and effectiveness in treating the uncontrolled movements and rigidity ("freezing") that can be caused by levodopa. The investigational drug attempts to block chemicals in the brain that can contribute to movement disorders.

Study inclusion / exclusion criteria

• At least 30 years old
• Diagnosed with moderate to severe Parkinson’s disease for at least 5 years
• On a stable dose of levodopa for at least 2 years
• Experiencing uncontrolled movements or "freezing" due to levodopa treatment

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: February 25, 2008 at 3:26:00 PM